Soleil Securities Upgrades LifePoint Hospitals (LPNT) to Buy; Trading at Low Valuation
Soleil Securities upgrades LifePoint Hospitals (Nasdaq: LPNT) from Hold to Buy. Price target $32.75.
Soleil analyst says, "We met with management at the company's Nashville headquarters and left with the impression that considerable progress has been made in putting LifePoint on the track for long-term growth...Our price target for LPNT is $32.75 and is based on the view that the company's shares can trade to 12x our 2010 EPS estimate of $2.73 over the next year. This price objective would still value LifePoint below its historical forward P/E multiple of 14-18x. At yesterday's close, LPNT trades at an industry low 9.9x our 2010 EPS estimate and has a modest EV/EBITDA valuation on 2010 numbers of 6.2x."
To see more analyst ratings on LPNT Click Here.
LifePoint Hospitals Inc., through its subsidiaries, owns and operates general acute care hospitals in non-urban communities in the United States.
Related Categories
UpgradesStocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
